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Abstract
Background: Neurogenesis persists throughout life in the adult mammalian brain. Because neurogenesis can only be
assessed in postmortem tissue, its functional significance remains undetermined, and identifying an in vivo correlate of
neurogenesis has become an important goal. By studying pentylenetetrazole-induced brain stimulation in a rat model of
kindling we accidentally discovered that 2561 days periodic stimulation of Sprague-Dawley rats led to a highly efficient
increase in seizure susceptibility.
Methodology/Principal Findings: By EEG, RT-PCR, western blotting and immunohistochemistry, we show that repeated
convulsive seizures with a periodicity of 2561 days led to an enrichment of newly generated neurons, that were BrdU-
positive in the dentate gyrus at day 2561 post-seizure. At the same time, there was a massive increase in the number of
neurons expressing the migratory marker, doublecortin, at the boundary between the granule cell layer and the
polymorphic layer in the dorsal hippocampus. Some of these migrating neurons were also positive for NeuN, a marker for
adult neurons.
Conclusion/Significance: Our results suggest that the increased susceptibility to seizure at day 2561 post-treatment is
coincident with a critical time required for newborn neurons to differentiate and integrate into the existing hippocampal
network, and outlines the importance of the dorsal hippocampus for seizure-related neurogenesis. This model can be used
as an in vivo correlate of neurogenesis to study basic questions related to neurogenesis and to the neurogenic mechanisms
that contribute to the development of epilepsy.
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Introduction
Pentylenetetrazole (PTZ) is a GABA-A antagonist. By studying
PTZ-induced brain stimulation in a rat model of aging we
discovered that periodic PTZ-stimulation of Sprague-Dawley rats
at 2561 day intervals led to a highly efficient increase in seizure
susceptibility [1]. Specifically, a high proportion (over 70%) of
animals reached full kindling status after only two subconvulsant
doses of pentylenetetrazole (PTZ) (30 mg/kg) given 25 days apart;
we dubbed this model the critical time window kindling model [1].
Although this work suggested that the persistent expression of
several classes of brain plasticity-associated proteins may be
required for the maintenance of kindling status, the results do not
explain the 2561 day periodicity of seizure susceptibility. Hence,
it seemed likely that other cellular events might be involved.
Subsequent studies on stimulation-induced neurogenesis in the
adult hippocampus have revealed that, at 3 wks after stimulation,
the newly generated neurons have an intrinsic excitability [2–4].
Therefore, in the present study, we tested the hypothesis that the
critical interval determining the exquisite sensitivity of the brain to
repeated exposure to PTZ is governed by the timing of neurogenesis in
affected regions.
Materials and Methods
All experimental procedures were approved by the Institutional
Animal Care and Use Committee of the State M-V (approval
number: LALLF M-V/TSD/7221.3-1.1-044/08) and by the
Institutional Animal Care and Use Committee of the Medical
University of Craiova.
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Three-mo-old male Sprague-Dawley rats were maintained on a
12 h light/dark cycle and allowed free access to food and water.
The body weights ranged from 320–400 g. A total of 212 rats were
used.
Administration of pentylenetetrazole (PTZ)
Each experiment was performed with groups of 15–20 young-
adult male rats for each timepoint at which the animals were
sacrificed.
Experiment 1: A single seizure episode and
cytogenesis. Convulsive seizures were elicited by a single
convulsant injection of PTZ (50 mg/kg). To label the newly
generated cells, rats were given injections of bromodeoxyuridine
(BrdU; 50 mg/kg body weight, i.p.; Roche, Germany) at days 1–3
post-seizure (Fig. 1). The animals were sacrificed at day 24 post-
seizure and the distribution of proliferating, BrdU-positive cells in
the brain analyzed as described below.
Experiment 2: Full kindling status and cytogenesis. To
induce full kindling status (scores 4 and 5 according to Racine) [5],
rats were primed first with a convulsive dose of PTZ at 50 mg/kg.
Kindling criterion was maintained by four subsequent subconvul-
sive doses of PTZ (30 mg/kg) given 2561 days apart [1]. In order
to evaluate cell accumulation and cellular phenotype, rats were
given BrdU (50 mg/kg, i.p.) at days 1, 2 and 3 after each PTZ
treatment (Fig. 2A). The animals were sacrificed at day 125 post-
seizure and the brains analyzed as described below.
Experiment 3: Achievement of kindling status by repeated
treatment with a subconvulsive dose of PTZ. To induce full
kindling status, rats were treated i.p. with subconvulsant doses of
PTZ at a concentration of 30 mg/kg, given 25 days apart over a
total period of 100 days [1]. In order to evaluate cell accumulation
and cellular phenotype, rats were given BrdU (50 mg/kg, i.p.) at
days 1, 2 and 3 after each PTZ treatment (Fig. 2B). The animals
were sacrificed at day 125 post-seizure and the brains analyzed as
described below.
Experiment 4: Neurogenesis stimulation by treatment
with L-NAME. Treatment with the Nv-nitro-L-arginine meth-
yl ester nitric oxide synthase inhibitors such as Nv-nitro-L-
arginine methyl ester (L-NAME) has been shown to stimulate
neurogenesis in the rat hippocampus [6,7]. To test the
neurogenesis hypothesis of kindling more directly, rats were
treated i.p. with a subconvulsant dose of PTZ at a concentration
of 30 mg/kg on day 0. During the PTZ treatment we observed a
transient increase in blood pressure that peaked at 6 hrs post-
administration (unpublished). In order to avoid the additional
effect of increased blood pressure caused by L-NAME [6,7], we
started the L-NAME treatment (90 mg/kg per day, i.p.) on day 1
and completed treatment on day 24.
Initially, L-NAME was administered for 14 days following
published protocols [6]. However, the effect this duration of L-
NAME treatment on seizure susceptibility was not significantly
different between control and treated animals. For this reason, the
L-NAME treatment was extended to 24 days. A second PTZ
injection was given on day 25 and the brains were analyzed on day
50 post-seizure. Control rats for all groups received i.p.
physiological saline.
EEG Recordings
Under anesthesia, animals were positioned in a stereotaxic
frame, a midline incision was made along the scalp, which was
reflected bilaterally and 2 burr holes were made in the skull
(bregma for positive wire and lambda for negative wire), but did
not perforate the dura. The electrode wire was secured to the skull
surface with dental acrylic. The skin around the headset was
sutured and the animals were allowed to recover from anesthesia.
Lesioned animals recovered for 1 week before monitoring, to
ensured complete recovery from anesthesia and the local effects of
surgery. Qualitative EEG analysis was performed by visual
examination of the record with attention paid to generalized and
intermittent focal epileptic activities. Epileptic activities were
distinguished from non-epileptic activities based on changes in
waveform morphology, amplitude, and frequency, as well as the
associated absence or presence of behavioural change.
Tissue Processing
Following various survival times, the rats were deeply anesthe-
tized with 3% halothane in 75% nitrous oxide/25% oxygen, and
perfused with buffered saline. The brains were removed and
bisected midsagitally. One half of each brain (left and right
hemispheres were collected alternately) was fixed in 4% parafor-
maldehyde dissolved in 50 mM phosphate buffer (pH 7.2) for
24 hr, cryoprotected in 20% sucrose in 10 mM phosphate-
buffered saline (pH 7.2), and stored at 270uC. This hemisphere
was used for immunohistochemistry; the hippocampus and
temporal neocortex from the contralateral hemisphere were used
for biochemical analyses.
RNA Isolation
Total RNA was isolated using TRIzol reagent (Invitrogen Life
Technologies, Karlsruhe, Germany), as described by the manu-
facturer, followed by DNase 1 (Invitrogen Life Technologies,
Karlsruhe, Germany) digestion and further purification using the
RNeasy Mini extraction kit (Qiagen, Hilden, Germany). Purified
total RNA was used for real-time PCR quantification.
Real-time Reverse Transcriptase PCR (RT-PCR)
Total RNA was isolated from individual frozen hippocampal
homogenates using the RNeasy Mini extraction kit (Qiagen,
Hilden, Germany). For RT-PCR, 200 ng of total RNA was
reverse-transcribed using random hexamers and the reverse
transcription reagents (Superarray, Frederick, MD, USA). The
assay was set up with 8 ng of reverse-transcribed RNA and
GAPDH as an internal normalizer. Intron-spanning primer
specific for DCX and nestin were supplied by BIOMOL
(Hamburg, Germany). Amplification reactions were performed
using a kit supplied by BioRad on a real-time PCR cycler (MyiQ,
Thermal Cycler, BioRad, Munich).
Immunohistochemistry
Sections (25 mm-thick) were cut on a freezing microtome and
processed for immunohistochemistry as free-floating material. To
obtain uniform staining of all tissue sections, we used an
automated device (PCT, Device assembly for preparing and
analyzing tissue for microscopic examinations; patents: DE 199 45
621 A1 and WO 01/22052 A1, 2001) that makes it possible to
process and stain all sections simultaneously under identical
conditions. Using the automated staining device, immunohisto-
chemistry was conducted as previously described [1]. Briefly, after
incubation with blocking solutions containing 3% donkey serum/
10 mmol/l PBS/0.3% Tween 20, tissue sections were exposed
overnight at 4uC to one of the following antibodies: (1) guinea pig
anti-doublecortin (DCX) (1:8000, Millipore, Schwalbach, Ger-
many); (2) mouse anti-nestin (1:3000, Millipore, Schwalbach,
Germany); or (3) mouse anti NeuN (1:1000, Millipore, Schwal-
bach, Germany), each diluted in PBS containing 3% normal
donkey serum and 0.3% Tween 20. After extensive washing in
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PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e39302Figure 1. Diagrams. (Upper panel): Flow diagram of Exp. #1 regarding times and type of treatment with pentylenetetrazole. (Lower panel):
Schematic diagram of the distribution of proliferative (BrdU-positive) cells in the brain at day 25 after a single administration of a convulsive doseo f
PTZ. Note the change from a widespread distribution (A) to a more restricted distribution at 25 days post-seizure (B). In control rats, there were only a
few BrdU-positive cells, often in a duplex, mitosis-like state (C, D, E). Many proliferative cells in PTZ-treated animals appeared to enter the brain from
the circulation via leptomeningeal blood vessels (F, arrow points to a mitosis-like state). (G, H): Quantitation of BrdU-positive cells. One episode of
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4uC with host-specific biotinylated seconday antibodies (Dianova,
Hamburg, Germany) diluted 1:2000 in PBS containing 1%
normal donkey serum and 0.3% Tween 20. Finally sections were
incubated with ABC Elite reagent (Vectastain Elite Kit, Linaris,
Mannheim, Germany) diluted 1:100 in PBS containing 0.3%
Tween 20. The antibody complex was then visualized manually
with 0.025% 39,39 diaminobenzidine (DAB) and 0.005% hydrogen
peroxide in 100 mmol/l Tris buffer (pH 7.5).
For BrdU detection, free-floating sections were pre-treated with
50% formamide, 0.3 M NaCl, 10 mM sodium citrate at 65uC for
2 h, incubated in 2 M HCl at 37uC for 45 min, and rinsed in
0.1 M borate buffer (pH 8.5) at room temperature for 10 min.
After neutralization, sections were incubated in blocking solution
containing 10% lamb serum, 0.3% Triton X-100 in PBS overnight
at 4uC, followed by mouse anti-BrdU antibody (1:300, Roche,
Mannheim, Germany) at 4uC for 24 hr. Sections were washed
with PBS, incubated with biotinylated donkey anti-rat secondary
antibody (1:2000; Dianova, Hamburg, Germany) followed by the
avidin–biotin peroxidase complex (Linaris, Mannheim, Germany)
for 24 hrs. The horseradish peroxidase reaction was detected with
0.05% DAB and 0.03% H2O2. To visualize nuclei, some sections
were counterstained with methyl green.
Cell Counting
A quantitative estimate of the number of BrdU-, and DCX-
immunopositive cells was obtained by counting cells on every
tenth section across the entire hippocampal volume. To this end, a
sequence of confocal counting images of 1616242625 mm, spaced
0.1 mm apart across a 25 mm-thick section and covering 30% of
the infarcted area, was taken for fluorescently labeled cells as
previously described [8]. The resulting images were loaded into
the 3-D analysis software ‘‘Volocity’’ (IMPROVISION, Coventry,
UK) and computed using a Macintosh computer. The relative
mean number of BrdU-positive cells was then calculated per group
and time point and treatment by multiplying the number of cells
per section times 3.3 (the counting boxes that were quantitated
covered one third of the area of each section) times the section
interval of 10.
Because of the asymmetry in the distribution of DCX, however,
for DCX we counted every 5
th section in the dorsal hippocampus
and every 10
th section in the ventral hippocampus.
Cellular Phenotyping
Neuronal phenotype. Sections were double-immunolabeled
with guinea pig anti-DCX antibodies (1:4000, Millipore, Schwal-
bach, Germany) and rat anti-BrdU antibodies (1:1000; AdSerotec,
Duesseldorf, Germany). The antigen-antibody complexes were
visualized with donkey anti-guinea pig Cy2-conjugated antibodies
(1:2000) and donkey anti-rat or donkey anti-mouse Rhodamine-
conjugated antibodies (1:3000), respectively. In other experiments,
sections were double-immunolabeled with mouse anti-NeuN
antibodies (1:1000, Millipore, Schwalbach, Germany) and rat
anti-BrdU antibodies (1:2000; AdSerotec, Duesseldorf, Germany).
The antigen-antibody complexes were detected with donkey anti-
mouse Cy2-conjugated antibodies (1:2000) and donkey anti-rat
rhodamine-conjugated antibodies (1:3000; Dianova, Hamburg,
Germany), respectively.
Western Blotting
For immunoblotting, SDS-PAGE-separated proteins were
transferred to nitrocellulose membranes by semidry blotting.
The membrane was then incubated with guinea pig anti-DCX
antibodies (1:4000, Millipore, Schwalbach, Germany) and the
antigen-antibody complex was detected with goat anti-guinea pig-
conjugated alkaline phosphatase antibodies (1:8000; Jackson
ImmunoResearch, West Grove, PA) using Luminol (Pierce,
Amsterdam, Holland) as a substrate. For normalization, the
immunoblots were incubated with rabbit anti-GAPDH antibodies
(1:5000, clone 14C10, Cell Signaling Technology, Danvers, MA).
The immunoblots were scanned and analyzed with Kodak 1D
Software.
Microscopy
For light microscopy, a Nikon Eclipse microscope (Duessel-
dorf, Germany) was used. The digital images were arranged and
labeled using Adobe Photoshop. Confocal analysis of sections
was performed using a Nikon Eclipse microscope equipped with
a laser device from Visitech (Munich, Germany). 3-dimensional
reconstruction of overlapping antigens was achieved by taking a
sequence of confocal images that were spaced 0.1 mm apart
across a 25 mm-thick section. The resulting images were loaded
into the 3-D analysis software ‘‘Volocity’’ (IMPROVISION,
Coventry, UK) and computed using a MacIntosh computer.
Statistical Analysis
Data are presented as means 6 SD of two to five independent
experiments. All data, including behavioural scoring, EEG
parameters or cell counting were scored and measured in a
reviewer-blind manner. The results of cell quantitation were
evaluated by one-way ANOVA followed by Tukey post-hoc
analyses using SPSS software (SPSS Inc., Chicago, Illinois). The
level of significance was set at p,=0.05, two-tailed test.
Physiological data were analyzed by one-way repeated measures
analysis of variance on ranks.
Results
Experiment 1: Seizure is Associated with Selective
Cytogenesis in Brain
A single episode of PTZ-induced convulsive seizure caused the
appearance at day 3 of large numbers of BrdU-positive cells
having a non-preferential distribution in the entorhinal and
temporal neocortices as well as the hippocampal formation
(Fig. 1A). Many of these cells were in a mitosis-like state in the
dentate gyrus, polymorphic cell layer of the hippocampus, and
neocortex (not shown). After 25 days, most of the cells died but,
unexpectedly, there was also a selective survival of BrdU-positive
cells, especially those located in the hippocampus and temporal
neocortex (Fig. 1B).
In control rats, there were only a few BrdU-immunopositive
cells that were scattered randomly, often in a doubled, mitosis-like
state, especially in the temporal neocortex (Fig.1 C), entorhinal
convulsive seizure causes, at day 3, dramatically increased BrdU-positive cell numbers in the hippocampus (15-fold over controls; p=0.001) (G) and
temporal neocortex (22.5-fold over controls; p=0.001) (H). Although the numbers of BrdU-positive cells decreased dramatically by day 25, their
number remained, nonetheless, at relatively high levels in the hippocampus (4.8-fold; p=0.001)(G) and temporal neocortex (5.6-fold; p=0.001) (H)
over control levels. N=15 rats for each timepoint. Abbreviations: Te-II, temporal neocortex layer II; Ent, entorhinal neocortex; HC, hippocampus; lep,
leptomeninx. Bars: (C, D, E), 20 mm; (F), 30 mm.
doi:10.1371/journal.pone.0039302.g001
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proliferative cells in PTZ-treated animals appeared to have
entered the brain via the leptomeninges; many of these cells
retained a mitosis-like appearance (Fig. 1F, arrow).
By day 3 post-seizure, the number of BrdU-positive cells
(BrdU+) increased 16-fold in the hippocampus (Fig. 1G) and 10-
fold in the temporal neocortex (Fig. 1H) of PTZ-treated rats. After
25 days, the number of BrdU+ cells remained high in the
hippocampus and the temporal neocortex, albeit at much lower
levels than at day 3 (Fig. 1G, H).
Experiment 2: Full Kindling Status is Achieved after 3
Doses of PTZ
In this experiment, the rats were primed with a convulsive dose
(50 mg/kg) of PTZ followed by four subconvulsive doses (30 mg/
kg) of PTZ given 25 days apart, as shown in Fig. 2A. After two
injections of a subconvulsive dose of PTZ, up to 86% of rats
achieved full kindling status. Thereafter, the proportion of animals
showing full kindling status remained essentially constant (Fig. 2C).
By comparison, 31% of rats administered a subconvulsive dose of
PTZ at all times reached full kindling status after two injections
(Fig. 2C), and up to 81% reached full kindling status after the
fourth treatment (Fig. 2C). In contrast, rats given three consec-
utive, subconvulsive injections of PTZ every 30 days showed a very
low incidence of full kindling status (12%).
EEG Recording
A subconvulsive PTZ treatment elicited intermittent non-ictal
events that are typically dependent on the behavioral state of the
animal (active or passive wakefulness)(Fig. 2D). After the second
PTZ injection, the animals usually demonstrated mild multifocal
body jerks (Fig. 2E). After the third PTZ injection, the animals
showed typical seizure activity associated with motor arrest
(Fig. 2F).
Some of the BrdU-positive Cells are New Neurons
Each PTZ treatment led to an accumulation of BrdU
+ cells that
were most numerous in the dentate gyrus of the kindled rats
(Fig. 3A). 3D projections of confocal BrdU(red)/NeuN(green)
double-labeled images from PTZ-treated animals, revealed that 50
days was sufficient time to allow some BrdU-positive cells to
differentiate into neurons, particularly in the granule cell layer
(Fig. 3C, arrows). The number of double-labeled BrdU(red)/
NeuN(green) increased with the number of PTZ injections and
reached a maximum in kindled animals (Fig. 3D, E). In the
temporal neocortex, some cell nuclei also displayed a mixed
NeuN-BrdU phenotype in layers II and III (Fig. 3B, insets).
However, it is worth mentioning that not all BrdU-positive cells
become neurons. For example, in the subgranular zone, a known
neurogenic site, some of the BrdU-positive cells were incorporated
into the nuclei of endothelial cells in large blood vessels (Fig.3C,
inset). BrdU-positive nuclei were not found in microglia or
astrocytes (not shown).
Repeated PTZ Treatment at 25-day Intervals Led to the
Accumulation of the Neuronal Lineage Marker,
Doublecortin (DCX), in the Dorsal Hippocampus
At day 25 following the last PTZ treatment, DCX antigens were
preferentially localized at the border between the granule cell layer
and hilus of the dorsal hippocampus (Fig. 4B, arrows), and only
sporadically in the ventral hippocampus (Fig. 4A, arrows).
Moreover, it was only the dorsal hippocampus that showed
significant changes in number and phenotype of the DCX-positive
(DCX
+) cells (Fig. 4C). In enlarged images from kindled animals, it
became clear that the DCX-positive cells had extensions
penetrating the densely packed granule cell layer (Fig. 4D, arrows).
3D projections of DCX (green)/NeuN(red) double-labeling
images from 26PTZ treated animals indicate a clear, unexpected
co-localization of DCX and NeuN-positive cells along the hilus/
granule cell border in the dorsal hippocampus (Fig. 4E, arrows).
3D projections of DCX (green)/BrdU(red) double-labeling images
from 16 PTZ treated animals revealed a clonal appearance of
such cells (Fig. 4F, inset). With increasing time, the BrdU-labeled
nucleus of DCX (green)/BrdU(red) co-labeled cells became
fragmented and the number of DCX-positive cells increased
dramatically in kindled animals (Fig. 4F). Intriguingly, in kindled
animals the double-labeled cells also had a clonal appearance
(Fig. 4F, inset).
A quantitative estimate of DCX mRNA by RT-PCR revealed,
relative to control rats, a robust increase in the relative amount of
DCX transcripts at day 25 after the last seizure episode in kindled
animals (Fig. 4G). The actual increases are probably larger,
inasmuch as dorsal-ventral asymmetry in DCX expression would
have been neutralized by the homogenization of the entire
hippocampus.
We previously reported that optimal kindling status is achieved
when PTZ is administered within a tight time window of 2561
day [1]. In the present study, we found that the number of DCX
+
cells also is maximal when PTZ is administered every 25
th day
(Fig. 4H, filled circles) as opposed to every 30
th day (Fig. 4H, open
circles). The classical, rostral migratory stream (RMS) from the
lateral ventricle to the olfactory bulb did not show significant
kindling-related changes in the number of DCX-positive cells (data
not shown).
L-NAME Treatment Significantly Increases Neurogenesis
and Seizure Susceptibility
When administered systemically, L-NAME has been shown to
stimulate neurogenesis in the rat hippocampus by inhibiting NO
synthase [6–7,9]. We found that daily treatment with L-NAME
for 24 days (Fig. 5A) resulted in a significant increase in the
number of fully seizing animals after the second PTZ
administration on day 25 (Fig. 5B).
An early post-seizure event was a transient increase in nestin
mRNA and protein levels in the rat hippocampus. As previously
described, in control animals, nestin immunoreactivity is detected
in capillary walls (Fig. 5C) [8]. PTZ-evoked seizure activity led to a
dramatic increase (7.8-fold) in nestin mRNA levels at day 3 post-
seizure (Fig. 5D) that lasted for several days before returning to
control levels by day 25. L-NAME treatment did not change PTZ-
Figure 2. Flow diagrams of the experimental design regarding times and type of treatment and EEG recording. After Exp. #2( A) the
proportion of rats that achieved full kindling status reached 80% (C; p=0.001). By comparison, 31% of rats administered a subconvulsive dose of PTZ
at all times (Exp. #3)(B) reached full kindling status after two injections and up to 81% of animals reached full kindling status after the fourth
treatment (C; p=0.001). (D–F): A subconvulsive PTZ treatment elicited intermittent non-ictal events that are typically dependent on the behavioral
state of the animal (active or passive wakefulness)(D). After the second PTZ injection, the animals usually demonstrated mild multifocal body jerks (E).
After the third PTZ injection, the animals showed typical seizure activity associated with motor arrest (F).
doi:10.1371/journal.pone.0039302.g002
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treated animals had significantly more (2.7-fold) nestin mRNA
than did animals treated with PTZ alone at day 25 (Fig. 5D).
Kindled animals did not show an increased level of nestin mRNA
(Fig. 5D). This is not surprising, in that nestin mRNA levels were
measured well after seizure activity ceased, and always shortly
before a new PTZ treatment. At the tissue level, nestin
immunoreactivity at day3 in PTZ-treated animals was confined
to radial glia-like cells in the inner molecular layer of the dentate
gyrus, the polymorphic layer and, interestingly, to the CA2 region
(Fig. 5E, and inset). After 25 days, the nestin-like immunoreactivity
was restricted to the polymorphic layer (Fig. 5F and inset).
Figure 3. Number and phenotyping of BrdU-positive cells after seizure activity. Each PTZ treatment led to an accumulation of BrdU
+ cells
in the dentate gyrus of the kindled rats (9-fold, p=0.0001; A). (B–E): 3D projections of confocal BrdU(red)/NeuN(green) double-labeled images from
PTZ-treated animals. A single episode of seizure activity led to the appearance of BrdU-positive cells in the polymorphic layer that were in a mitosis-
like state (B). Occasionally some neurons in layers II and III of the temporal neocortex also displayed BrdU
+ cells in close apposition to neurons (B,
insets). After 26PTZ some BrdU-positive cells have differentiated into neurons, particularly in the granule cell layer (C, arrows). In addition, some
BrdU-positive nuclei were detected in the walls of large blood vessels (C, inset). The number of double-labeled BrdU(red)/NeuN(green) increased with
the number of PTZ injections and reached a maximum in the granule cells layer of kindled animals (D, low power; E, higher power). Abbreviations: Te,
temporal neocortex; GCL, granule cell layer; BV, Blood Vessel.
doi:10.1371/journal.pone.0039302.g003
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Rat Hippocampus
In PTZ-treated animals, DCX immunoreactivity on Western
blots was increased, a phenomenon that was accentuated by the
combined PTZ + L-NAME treatment at day 50 post-seizure
(Fig. 6A, B). Most importantly, increased DCX levels persisted in
kindled animals as well (Fig. 6A, C). Due to homogenization
procedures that eliminated hippocampal asymmetry, the differ-
ences in the net intensity of DCX on western blots between control
and treated animals was less evident but nevertheless significant.
By immunohistochemistry, numerous DCX-positive cells were
detected in the subgranular zone of the dorsal hippocampus of L-
NAME-treated animals by day 50 post-seizure (Fig. 6C). Quan-
titatively, L-NAME elicited significant increases in the number of
DCX-positive cells in the dentate gyrus by 1.5-fold (Fig. 6D).
Figure 4. Localization and quantification of DCX in the rat brain during kindling development. (A, B) Overview of DCX staining in the
ventral (A, arrows) and dorsal (B, arrows) hippocampal hilus of the kindled animals. The dorsal hippocampus of kindled animals, was highly
significant (p=0.001) enriched in DCX
+-cells (C). Note that the DCX antigens were localized both in cell bodies and extensions penetrating the
densely packed granule cell neurons (D, arrows). (E-F): Phenotyping of DCX-cells. After 26 PTZ some DCX
+ positive cells (green) in the dorsal
hippocampus along the hilar border with the granule cell layer had a NeuN nucleus (red) (E, arrows). In kindled animals some of the DCX (green)/
BrdU (red) double-labeled cells had a clonal appearance (F, inset, 3D-image) while other DCX
+ cells (green) sometimes displayed a fragmented BrdU-
positivity (F, arrow). By quantitative RT-PCR there was a 3-fold increase (p=0.01) in the relative amount of DCX transcripts in kindled animals over
that of controls (G). Note that the number of DCX
+ cells also is maximal when PTZ is administered every 25
th day (Fig. 4H, filled circles) as opposed to
every 30
th day (H, open circles). Abbreviations: gcl, granule cell layer; hl, hilus; pml, polymorphic layer. Bars: (A,B), 200 mm; (D), 100 mm.
doi:10.1371/journal.pone.0039302.g004
Figure 5. L-NAME treatment increased neurogenesis and seizure susceptibility. Daily treatment with L-NAME for 24 days (A) resulted in a
significant increase in the number of fully seizing animals after the second PTZ administration on day 25 (B). In control animals, nestin
immunoreactivity was detected in capillary walls (C). By quantitative RT-PCR there was a 7.8-fold (p=0.001) in nestin mRNA levels at day 3 post-
seizure (D). L-NAME-treated animals had significantly more (2.7-fold; p=0.001) nestin mRNA than did animals treated with PTZ alone at day 25 (D)
whereas kindled animals did not show an increased level of nestin mRNA (D). At the tissue level, nestin immunoreactivity at day3 in PTZ-treated
animals was confined to radial glia-like cells in the inner molecular layer of the dentate gyrus, the polymorphic layer and, interestingly, to the CA2
region (arrow) (E, and inset). After 25 days, the nestin-like immunoreactivity was restricted to the polymorphic layer (F and inset). Abbreviations: DG,
dentate gyrus; pml, polymorphic layer; CA2, hippocampal region.
doi:10.1371/journal.pone.0039302.g005
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In this study, we show that, at day 2561 following stimulation
of the brain by seizure-evoking pharmacological manipulations,
Sprague-Dawley rats are extremely susceptible to the development
of kindling status if they are subsequently primed with two
subconvulsive dose of pentylenetetrazole (PTZ) given 25 days
apart. Mechanistically, every 25
th but not 30
th day stimulation of
the brain by PTZ enlarges the population of new, migratory
neurons in the subgranular zone of the hippocampal dentate
gyrus.
Because of the close resemblance to the time window of one
month needed for neuronal development and maturation of newly
born neurons in the adult hippocampus, we hypothesized that
seizure susceptibility at day 25 is related to some critical timepoint-
related integration of newly generated neurons. For this reason, we
investigated systematically the time-course of cytogenesis as related
to seizure susceptibility. Initially, PTZ-induced a uniform distri-
bution of proliferating cells in many regions of the brain. The
origin of these cells is not clear, but some were certainly
penetrating the brain via the leptomeninges. However, the
presence of a large number of BrdU-positive cells at day 3 after
a single PTZ administration makes it unlikely that so many cells
had been generated, or launched into a proliferative state, after
seizure activity. Rather, it is reasonable to think that many of them
are progenitor cells from the circulation that enter the brain via
the leptomeningeal vasculature, a process facilitated by seizure
activity, which can compromise the blood-brain barrier [10]. Such
circulation-derived progenitor cells could become neurons [11] or
even fuse with endogenous cells [12].
After 25 days, most of the BrdU-positive cells have disappeared
except in the hippocampus and the temporal neocortex, suggesting
a preferential survival of some BrdU-positive cells that also became
DCX-positive. Upon reaching a critical threshold of cells positive
for DCX (a marker of immature neurons) which was usually
achieved after 3 doses of PTZ, most of the animals showed an
EEG typical of seizure activity; they also achieved full kindling
status, suggesting that seizure susceptibility is related both to a
certain level of immature neurons and a certain developmental
period. Intriguingly, we found that 26 PTZ treatment led to an
increase in the number of cells in which DCX and NeuN co-
localized. The presence of DCX in mature neurons also has been
recently reported in the adult CNS [13].
Among early cell phenotypes, we noted the expression of the
neuroepithelial and radial glia marker, nestin. Of note, nestin
expression also was increased in the CA2 region of the
Figure 6. L-NAME treatment increased doublecortin levels in the rat hippocampus. L-NAME treatment increased DCX immunoreactivity on
Western blots (A) by 2.2-fold (p=0.02) at day 50 post-seizure (B). By immunohistochemistry, numerous DCX-positive cells were detected in the
subgranular zone of the dorsal hippocampus by day 50 post-seizure (C). Quantitatively, L-NAME elicited significant increases (1.5-fold, p=0.01) in the
number of DCX-positive cells (D). Abbreviations: gcl, granule cell layer.
doi:10.1371/journal.pone.0039302.g006
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early increase in proliferating radial glia-like astrocytes in the
dentate gyrus after kainate-induced seizures that is consistent
with a recruitment of precursors for seizure-induced neurogenesis
also has been previously reported [15,16]. However, after 24
days there were only a few nestin-like cells remaining in the
polymorphic layer of the dentate gyrus. Nevertheless, at the same
time, the number of DCX-positive cells had increased, a
phenomenon amplified by the neurogenesis-stimulator L-NAME,
suggesting that certain niches like that of the hippocampus confer
selective survival capacity, and this process was reinforced after
application of PTZ every 24
th day. Further, long-term treatment
(4 wks) of rats with L-NAME has been shown to increase seizure
susceptibility upon administration of a convulsant dose of
pentylenetetrazole [17].
Upon reaching a certain threshold of DCX cells with deep
penetrating extensions in the granule cell layer, the animals
achieved kindling status. We noted that DCX is specifically
expressed at 25 days along the hilar border of the granule cell layer
in the dorsal hippocampus. Quite recently, we reported that a
kindling-specific isoform of the mitochondrial Rieske protein had a
similar localization in the critical time window kindling model
[18]. However, it is not clear at this time how DCX expression
could be related to Rieske protein expression in the dorsal
hippocampus, or how Rieske protein expression is linked to
neurogenesis.
The dorsal-ventral segregation of the hippocampal response to
seizure has been documented in mice [19], while the dorsal-
ventral hippocampal asymmetry in neurogenic response to
stimulants has been recently described for rats [20] and in humans
[21,22]. Finally, some of the BrdU-positive cells became NeuN-
positive and are regarded as fully mature neurons.
Our data are consistent with the hypothesis that seizure
susceptibility is associated with the developmental status of
seizure-generated new neurons in the dentate gyrus. Further,
seizure susceptibility could be either related to an enhanced
excitability of the newborn neurons or to a deregulation of the
existing neuronal network by inappropriate connections to existing
neuronal connections in the hippocampus. Consistent with the
increased excitability hypothesis of newly born neurons is a recent
study showing that during a maturation period of about one
month, the young neurons are more excitable than the neighbor-
ing ‘older’ cells and show a lower threshold for the induction of
synaptic plasticity than neighboring older granule cells [23].
Another study has shown that significant recruitment of new
neurons into the existing network did not occur until they were at
least 3 weeks old [4].
The enrichment of newly generated neurons by day 25
following PTZ treatment also suggests that neuronal differenti-
ation, dendritic growth and survival of the newly born neurons in
the dentate gyrus are strongly dependent on the experience of
the animal during a critical period of about 3 weeks after birth
[3,24–27].
Earlier studies have shown that dentate granule cell neurogen-
esis is increased by seizures and contributes to aberrant network
reorganization in the adult rat hippocampus [28]. We hypothesize
that, when the integration capacity of the Sprague-Dawley rats
exceeds a critical threshold, powerful new recurrent excitatory
circuits can be generated in the hippocampus [29–31] that serve as
the substrate for seizure activity. This hypothesis is supported by
several recent studies that showed that dentate granule cells
generated after seizure activity begin sending axons aberrantly into
the dentate inner molecular layer by day 24 after stimulation
[26,32–33].
The involvement of PTZ in synaptic re-organization is also
suggested by a recent study showing that chronic treatment with
pentylenetetrazole, at non-epileptic doses, causes a recovery of
cognition and long-term potentiation in Ts65Dn mice [34,35].
Ts65Dn mice have excessive inhibition in the dentate gyrus and
share several phenotypic characteristics with human Down
syndrome patients.
Conclusions
Periodic stimulation of the brain by seizure-evoking pharmaco-
logical manipulations, performed within the developmental range
of hippocampal neurogenesis, enlarges the population of newly
generated migratory neurons in the subgranular zone of the
dentate gyrus. Such neurons can contribute to the formation of
new, recurrent excitatory circuits within the hippocampal forma-
tion [36].
Our study further suggests that seizure susceptibility due to
stimulus-induced neurogenesis may depend on the developmental
period of post-seizure newborn neurons, and could, therefore,
species-specific. For example, granule cell maturation in the
dentate gyrus of a nonhuman primate (macaque monkeys) requires
a minimum of a 6-mo time period, more than 6 times longer than
in rodents [37]. Since development of temporal lobe epilepsy in
humans may take 5–10 years to develop [38–41] this interval is
likely to be even longer in humans. Indeed, the risk of occurrence
of seizure activity in patients who have not been treated is about
50% after two years of follow-up [42].
The identification of this long, well-defined developmental
interval for inducing kindling status makes possible a dissection of
the cellular and genetic events underlying this phenomenon and its
relationship to normal and pathological brain function.
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